Galapagos NV (GLPG.AS) Stock Price
€27.64 0%
to add to portfolio
AI Score
-
Alternative
5 -
Fundamental
3 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Galapagos NV, AI stock picks, stock alerts and much more.
GLPG.AS AI Stock Analysis
AI stock analysis for GLPG.AS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Galapagos NV (GLPG.AS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Galapagos NV (GLPG.AS) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Galapagos NV (GLPG.AS), currently trading at €27.64, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About GLPG.AS
-
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need.
-
Symbol
GLPG.AS
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
1.8B
Similar Stocks
 |
Valneva SE VLA.PA |
€5.05 2.4% |
5 |
 |
Financière de Tubize SA TUB.BR |
€160.6 0.4% |
8 |
 |
OSE Immunotherapeutics SA OSE.PA |
€6.32 0.5% |
6 |
 |
UCB SA UCB.BR |
€197.3 0.9% |
6 |
 |
Innate Pharma S.A. IPH.PA |
€2.01 1.9% |
5 |
News
GLPG.AS Alternative Data
Web Traffic
Galapagos NV receives an estimated 34086 monthly visitors to glpg.com.
-
Web Traffic
34086
-
Change from Previous Month
15.8%
-
3 Month Change
60.5%
-
YoY Change
60.5%
Twitter Followers
Galapagos NV has 3,448 Twitter Followers on its main Twitter (also known as X) account, which is up by 0.1% over the last month.
-
Twitter Followers
3448
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Job Postings
Galapagos NV has an estimated 3 open job postings, which is down -25% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
25%
-
3 Month Change
76.9%
-
YoY Change
76.9%
Reddit Mentions
Galapagos NV has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
81,175 are following Galapagos NV on LinkedIn, up by 0.8% over the last month.
-
LinkedIn Followers
81175
-
Daily Change
0.8%
-
1 Month Change
0.8%
-
3 Month Change
3%
-
YoY Change
3%
LinkedIn Employees
According to LinkedIn, Galapagos NV has 961 employees, down by -2.1% over the last month.
-
LinkedIn Employees
961
-
Daily Change
2.1%
-
1 Month Change
2.1%
-
3 Month Change
7.6%
-
YoY Change
7.6%
Business Outlook
According to employee reviews, the business outlook among employees at Galapagos NV is 12 out of 100 (very bearish).
-
Business Outlook
12
-
Change from Previous Month
0%
-
3 Month Change
14.3%
-
YoY Change
14.3%
News Mentions
Galapagos NV was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
GLPG.AS Financials
GLPG.AS Key Metrics
-
Total Revenue
€75M
-
Net Income
-€153.4M
-
Earnings per Share
-€2.33
-
Free cash flow
-€43.9M
-
EBITDA
-€158.7M
-
EBITDA Ratio
-2.11676
-
Total Assets
€4B
GLPG.AS 2-year Revenue & Income
GLPG.AS 2-year Free Cash Flow
GLPG.AS Technicals
GLPG.AS SMA
GLPG.AS RSI
FAQ
What's the current price of Galapagos NV (GLPG.AS) Stock?
The price of an Galapagos NV (GLPG.AS) share is €27.64.
What's the market cap of Galapagos NV?
The current market cap of Galapagos NV is 1.8B.
Should I buy or sell GLPG.AS?
Galapagos NV shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Galapagos NV is better viewed as a hold or accumulate position while waiting for further developments.
Is Galapagos NV a good investment?
The current analysis of Galapagos NV's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Galapagos NV's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Galapagos NV (GLPG.AS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Galapagos NV stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Galapagos NV (GLPG.AS) that investors often compare it to?
Galapagos NV (GLPG.AS) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for Galapagos NV's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Galapagos NV's stock price to be around €26.88 in 2026. Starting from the current price of €27.64, this represents a 2.7% change in price, indicating a neutral outlook for the stock.
How to buy Galapagos NV (GLPG.AS) Stock?
Galapagos NV stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Galapagos NV shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.